Pharmacoeconomics of entecavir treatment for chronic hepatitis B.

@article{You2008PharmacoeconomicsOE,
  title={Pharmacoeconomics of entecavir treatment for chronic hepatitis B.},
  author={Joyce H S You and Fredric W H Chan},
  journal={Expert opinion on pharmacotherapy},
  year={2008},
  volume={9 15},
  pages={2673-81}
}
BACKGROUND Entecavir is a new antiviral agent for chronic hepatitis B virus (HBV) infection with potent HBV suppression and a low rate of viral resistance. OBJECTIVE To review published studies on the pharmacoeconomics of entecavir for treatment of chronic HBV. METHODS A literature search on Medline and Embase over the period of 1998 - 2008 was performed in April 2008 using keywords 'entecavir' and 'cost'. RESULTS/CONCLUSION Four studies comparing the cost effectiveness of entecavir with… CONTINUE READING